Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04529109
Other study ID # CR-6395
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 13, 2020
Est. completion date September 15, 2020

Study information

Verified date October 2021
Source Johnson & Johnson Vision Care, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This will be a randomized, double-masked, bilateral, cross-over, 2 treatment by 2 period dispensing study. There will be 4 visits. There will be a 2 to 5 day washout period between treatments.


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date September 15, 2020
Est. primary completion date September 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 29 Years
Eligibility Inclusion Criteria: -Potential subjects must satisfy all of the following criteria to be enrolled in the study: 1. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form 2. Females between 18 and 29 (inclusive) years of age at the time of screening 3. Appear able and willing to adhere to the instructions set forth in this clinical protocol (i.e. willing to wear only the study lenses and not use habitual lenses during the dispensing periods) 4. Be a current soft contact lens wearer in both eyes with a minimum of 6 hours/day and 5 days/week over the last month by self-report 5. Be a current wearer of cosmetic/circle lenses in the last 6 months, by self-report. 6. The subject must be willing to be photographed and/or video-taped 7. The subject's vertex corrected spherical equivalent distance refraction must be in the range of -1.00 D to -6.00 D (inclusive) in each eye 8. The subject's refractive cylinder must be less than or equal to 0.75 D (inclusive) in each eye 9. Have spherical best corrected visual acuity of 20/25 or better in each eye. Exclusion Criteria: 1. Currently pregnant or lactating 2. Any systemic disease (eg, Sjögren's Syndrome), allergies, infectious disease (eg, hepatitis, tuberculosis), contagious immunosuppressive diseases (eg, HIV), autoimmune disease (eg, rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with contact lens wear and/or participation in the study (at the investigators discretion) 3. Use of systemic medications (eg, chronic steroid use) that are known to interfere with contact lens wear (at the investigators discretion) 4. Any previous or planned (during the study) ocular surgery (eg, radial keratotomy, PRK, LASIK, etc.). 5. Any previous history or signs of a contact lens-related corneal inflammatory event (eg, past peripheral ulcer or round peripheral scar), or any other ocular abnormality that would contraindicate contact lens wear (at the investigators discretion). 6. Participation in any contact lens or lens care product clinical trial within seven (7) days prior to study enrollment 7. Employee or family members of clinical site (eg, Investigator, Coordinator, Technician) 8. Any ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or corneal distortion (at the investigators discretion) 9. Clinically significant (Grade 3 or 4 on FDA scale) tarsal abnormalities, bulbar injection, corneal edema, corneal vascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
etafilcon A investigational cosmetic lens 1
TEST
etafilcon A investigational cosmetic lens 2
CONTROL

Locations

Country Name City State
Hong Kong Vital Eyecare Center Mongkok Kowloon
Hong Kong Sight Enhancement Center Yau Ma Tei Kowloon
United States Stam & Associates Eye Care Jacksonville Florida
United States Frazier Vision, Inc Tyler Texas

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Vision Care, Inc.

Countries where clinical trial is conducted

United States,  Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of Eyes With Distance Monocular Visual Acuity (logMAR) Lower Than 0.176 logMAR Visual acuity on logMAR (Logarithm of Minimal Angle of Resolution) scale was evaluated at distance (4 meters) under high luminance high contrast lighting condition using ETDRS (Early Treatment Diabetic Retinopathy Study) charts. Letter-by-letter results calculated the visual performance score for each chart read. logMAR scores closer to zero, or below zero, indicate a better visual acuity. However, the data was dichotomized as Y=1 if logMAR visual acuity was less than 0.176 logMAR; and Y=0 otherwise. A value of 0.176 logMAR ?20/30 Snellen Visual Acuity. The proportion of eyes with visual acuity lower than 0.176 logMAR was reported. 5- Minutes Post-Lens Fitting
See also
  Status Clinical Trial Phase
Completed NCT06019806 - Effects of Forward Head Posture Correction on Visual Acuity in Low Level Visually Impaired University Students N/A
Completed NCT04567186 - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Hyperopic Population N/A
Completed NCT02568254 - Evaluation of Three Daily Disposable Contact Lenses N/A
Completed NCT01951703 - Senofilcon A Investigational Manufacturing Process N/A
Terminated NCT00637468 - EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye Phase 3
Recruiting NCT04632901 - A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
Active, not recruiting NCT03747601 - Temporal Interference Brain Stimulation N/A
Completed NCT06131476 - Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop Phase 1
Recruiting NCT05414565 - Post-Market Study of Alcon Intraocular Lenses
Completed NCT05056870 - Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats N/A
Completed NCT04615507 - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2 N/A
Completed NCT05099380 - Validation of Senofilcon A With New UV / HEV Filter N/A
Completed NCT03713281 - Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population
Completed NCT05582304 - Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study N/A
Completed NCT03742271 - Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population N/A
Completed NCT04995055 - Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function N/A
Completed NCT05554640 - Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses N/A
Completed NCT01926704 - MTF Image Modifications N/A
Completed NCT04649606 - Dynamic Characterisation of Meibomian Gland Structure
Completed NCT05101252 - Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product N/A